Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BeiGene, Ltd. | Director | Ordinary Shares | 46.2K | $9.61M | $207.72 | Jun 5, 2024 | Direct |
Ultragenyx Pharmaceutical Inc. | Director | Common Stock | 12K | $492K | $40.98 | Jul 2, 2024 | Direct |
BeiGene, Ltd. | Director | Share Option (Right to Buy) | 34.2K | Jun 5, 2024 | Direct | ||
Ultragenyx Pharmaceutical Inc. | Director | Stock Option (Right to Buy) | 9.9K | Jun 18, 2024 | Direct | ||
Molecular Templates, Inc. | Director | Stock Option (right to buy) | 1K | Sep 27, 2024 | Direct | ||
BeiGene, Ltd. | Director | American Depositary Shares | 0 | $180.50 | Jun 23, 2023 | Direct |